Removal of antibiotics in conventional and advanced wastewater treatment: Implications for environmental discharge and wastewater recycling

Water Research

Volumn 41, Issue 18, 2007, Pages 4164-4176

  Watkinson, A J ^a,b   Murby, E J ^c   Costanzo, S D ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Cooperative Research Centre for Water Quality and Treatment ^*  (Australia)

^c NATIONAL MEASUREMENT INSTITUTE   (Australia)

Author keywords

Activated sludge; Antibiotics; Environment; Microfiltration; Recycling; Reuse; Reverse osmosis; Water; WWTP

Indexed keywords

ACTIVATED SLUDGE PROCESS; ANTIBIOTICS; CONCENTRATION (PROCESS); EFFLUENTS; MICROFILTRATION; REVERSE OSMOSIS; TURBIDITY; WATER RECYCLING;

ENVIRONMENTAL DISCHARGE; ROXITHROMYCIN; WASTEWATER RECYCLING;

WASTEWATER TREATMENT;

AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFALEXIN; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; ENROFLOXACIN; ERYTHROMYCIN; LINCOMYCIN; LINCOSAMIDE DERIVATIVE; MACROLIDE; NALIDIXIC ACID; NITRATE; NORFLOXACIN; OLEANDOMYCIN; PENICILLIN G; PENICILLIN V; POLYETHER ANTIBIOTIC AGENT; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROXITHROMYCIN; SULFAMETHOXAZOLE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; TYLOSIN; UNINDEXED DRUG; WATER;

ACTIVATED SLUDGE PROCESS; ANTIBIOTICS; CONCENTRATION (PROCESS); EFFLUENTS; MICROFILTRATION; REVERSE OSMOSIS; TURBIDITY; WASTEWATER TREATMENT; WATER RECYCLING;

ACTIVATED SLUDGE; ANTIBIOTICS; DETECTION METHOD; ENVIRONMENTAL HAZARD; FILTRATION; OSMOSIS; POLLUTANT REMOVAL; RECYCLING; RISK ASSESSMENT; WASTEWATER; WATER TREATMENT;

ARTICLE; CONDUCTANCE; ENVIRONMENTAL FACTOR; MICROFILTRATION; PRIORITY JOURNAL; REVERSE OSMOSIS; TURBIDITY; WASTE WATER MANAGEMENT; WASTE WATER RECYCLING;

AUSTRALASIA; AUSTRALIA; BRISBANE; QUEENSLAND;

EID: 34548687233     PISSN: 00431354     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.watres.2007.04.005     Document Type: Article

References (77)

1. Adams C., Wang Y., Loftin K., and Meyer M. Removal of antibiotics from surface and distilled water in conventional water treatment processes. J. Environ. Eng. 128 3 (2002) 253-261
2. Alder A.C., McArdell C.S., Golet E.M., Ibric S., Molnar E., Nipales N.S., and Giger W. Occurrence and fate of fluoroquinolone, macrolide and sulfonamide antibiotics during wastewater treatment and in ambient waters in Switzerland. In: Daughton C.G., and Jones-Lepp T.L. (Eds). Pharmaceuticals and Personal Care Products in the Environment: Scientific and Regulatory Issues (2001), American Chemical Society, Washington, DC 39-54
3. Alexy R., Kumpel T., and Kummerer K. Assessment of degradation of 18 antibiotics in the Closed Bottle Test. Chemosphere 57 6 (2004) 505-512
4. Andreozzi R., Caprio V., Ciniglia C., De Champdore M., Lo Giudice R., Marotta R., and Zuccato E. Antibiotics in the environment: occurrence in Italian STPs, fate, and preliminary assessment on algal toxicity of amoxicillin. Environ. Sci. Technol. 38 24 (2004) 6832-6838
5. Andreozzi R., Canterino M., Giudice R.L., Marotta R., Pinto G., and Pollio A. Lincomycin solar photodegradation, algal toxicity and removal from wastewaters by means of ozonation. Water Res. 40 3 (2006) 630-638
6. ANZECC, 2000a. Australian and New Zealand Guidelines for Fresh and Marine Water Quality. Vol. 1. Agriculture and Resource Management Council of Australia and New Zealand, Australian and New Zealand Environment and Conservation Council.
7. ANZECC, 2000b. Guidelines for Sewerage Systems: Reclaimed Water. Agriculture and Resource Management Council of Australia and New Zealand, Australian and New Zealand Environment and Conservation Council: 42.
8. Ashton D., Hilton M., and Thomas K.V. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci. Total Environ. 333 (2004) 167-184
9. Batt A.L., Bruce I.B., and Aga D.S. Evaluating the vulnerability of surface waters to antibiotic contamination from varying wastewater treatment plant discharges. Environ. Pollut. 142 2 (2006) 295-302
10. Batt A.L., Snow D.D., and Aga D.S. Occurrence of sulfonamide antimicrobials in private water wells in Washington County, Idaho, USA. Chemosphere 64 11 (2006) 1963-1971
11. Bellona C., Drewes J.E., Xu P., and Amy G. Factors affecting the rejection of organic solutes during NF/RO treatment-a literature review. Water Res. 38 12 (2004) 2795-2809
12. Bistodeau T.J., Barber L.B., Bartell S.E., Cediel R.A., Grove K.J., Klaustermeier J., Woodard J.C., Lee K.E., and Schoenfuss H.L. Larval exposure to environmentally relevant mixtures of alkylphenolethoxylates reduces reproductive competence in male fathead minnows. Aquat. Toxicol. 79 3 (2006) 268-277
13. Boreen A.L., Arnold W.A., and McNeill K. Photodegradation of pharmaceuticals in the aquatic environment: a review. Aquat. Sci. 65 4 (2003) 320-341
14. Brain R.A., Wilson C.J., Johnson D.J., Sanderson H., Bestari K.J., Hanson M.L., Sibley P.K., and Solomon K.R. Effects of a mixture of tetracyclines to Lemna gibba and Myriophyllum sibiricum evaluated in aquatic microcosms. Environ. Pollut. 138 3 (2005) 425-442
15. Brown K.D., Kulis J., Thomson B., Chapman T.H., and Mawhinney D.B. Occurrence of antibiotics in hospital, residential, and dairy effluent, municipal wastewater, and the Rio Grande in New Mexico. Sci. Total Environ. 366 2-3 (2006) 772-783
16. Calamari D., Zuccato E., Castiglioni S., Bagnati R., and Fanelli R. Strategic survey of therapeutic drugs in the rivers Po and Lambro in northern Italy. Environ. Sci. Technol. 37 7 (2003) 1241-1248
17. Carballa M., Omil F., Lema J.M., Llompart M., Garcia-Jares C., Rodriguez I., Gomez M., and Ternes T. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res. 38 12 (2004) 2918-2926
18. Chamberlain E., and Adams C. Oxidation of sulfonamides, macrolides, and carbadox with free chlorine and monochloramine. Water Res. 40 13 (2006) 2517-2526
19. Clara M., Strenn B., Gans O., Martinez E., Kreuzinger N., and Kroiss H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res. 39 19 (2005) 4797-4807
20. Collignon P.J. Antibiotic resistance: is it leading to the re-emergence of many infections from the past. In: Asche V. (Ed). Recent Advances in Microbiology vol. 5 (1997), Australian Society for Microbiology Inc., Melbourne 203-256
21. Costanzo S.D., Murby J., and Bates J. Ecosystem response to antibiotics entering the aquatic environment. Mar. Pollut. Bull. 51 (2005) 218-223
22. Crane M., Watts C., and Boucard T. Chronic aquatic environmental risks from exposure to human pharmaceuticals. Sci. Total Environ. 367 1 (2006) 23-41
23. CSIRO, 2005. Urban water reuse: Why do we need to re-use water? 〈http://www.clw.csiro.au/priorities/urban/reclamation/index.html〉 Retrieved 15th April 2005.
24. Daughton C.G., and Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ. Health Perspect. 107 (1999) 907-938
25. Davison J. Genetic exchange between bacteria in the environment. Plasmid 42 2 (1999) 73-91
26. De Zuane J. Handbook of Drinking Water Quality (1997), Van Nostrand Reinhold, New York
27. Drewes J.E., Reinhard M., and Fox P. Comparing microfiltration-reverse osmosis and soil-aquifer treatment for indirect potable reuse of water. Water Res. 37 15 (2003) 3612-3621
28. Fasani E., Profumo A., and Albini A. Structure and medium-dependant photodecomposition of fluroqiunolone antibiotics. Photochem. Photobiol. 68 (1998) 666-674
29. Flaherty C.M., and Dodson S.I. Effects of pharmaceuticals on Daphnia survival, growth, and reproduction. Chemosphere 61 2 (2005) 200-207
30. Gibs J., Stackelberg P.E., Furlong E.T., Meyer M., Zaugg S.D., and Lippincott R.L. Persistence of pharmaceuticals and other organic compounds in chlorinated drinking water as a function of time. Sci. Total Environ. 373 (2007) 240-249
31. Giger W., Alder A.C., Golet E.M., Kohler H.P.E., McArdell C.S., Molnar E., Siegrist H., and Suter M.J.F. Occurrence and fate of antibiotics as trace contaminants in wastewaters, sewage sludges, and surface waters. Chimia 57 9 (2003) 485-491
32. Glassmeyer S.T., and Shoemaker J.A. Effects of chlorination on the persistence of pharmaceuticals in the environment. Bull. Environ. Contam. Toxicol. 74 1 (2005) 24-31
33. Gleick P. The World's Water 1998-1999 (1998), Island Press, Washington, DC
34. Golet E.M., Alder A.C., Hartmann A., Ternes T.A., and Giger W. Trace determination of fluoroquinolone antibacterial agents in urban wastewater by solid-phase extraction and liquid chromatography with fluorescence detection. Anal. Chem. 73 (2001) 3632-3638
35. Golet E.M., Alder A.C., and Giger W. Environmental exposure and risk assessment of fluoroquinolone antibacterial agents in wastewater and river water of the Glatt Valley Watershed, Switzerland. Environ. Sci. Technol. 36 17 (2002) 3645-3651
36. Golet E.M., Xifra I., Siegrist H., Alder A.C., and Giger W. Environmental exposure assessment of fluoroquinolone antibacterial agents from sewage to soil. Environ. Sci. Technol. 37 15 (2003) 3243-3249
37. Halling Sorensen B., Sengelov G., and Tjornelund J. Toxicity of tetracyclines and tetracycline degradation products to environmentally relevant bacteria, including selected tetracycline-resistant bacteria. Arch. Environ. Contam. Toxicol. 42 3 (2002) 263-271
38. Halling-Sorensen B., Lykkeberg A., Ingerslev F., Blackwell P., and Tjornelund J. Characterisation of the abiotic degradation pathways of oxytetracyclines in soil interstitial water using LC-MS-MS. Chemosphere 50 10 (2003) 1331-1342
39. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 131 1-2 (2002) 5-17
40. Heberer T., Dunnbier U., Reilich C., and Stan H.J. Detection of drugs and drug metabolites in ground water samples of a drinking water treatment plant. Fresenius Environ. Bull. 6 7-8 (1997) 438-443
41. Heberer T., Schmidt-Baumler K., and Stan H.J. Occurrence and distribution of organic contaminants in the aquatic system in Berlin. Part 1: drug residues and other polar contaminants in Berlin surface and groundwater. Acta Hydrochim. Hydrobiol. 26 5 (1998) 272-278
42. Hernando M.D., Mezcua M., Fernandez-Alba A.R., and Barcelo D. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 1st Swift-WFD Workshop on Validation of Robustness of Sensors and Bioassays for Screening Pollutants-1st SWIFT-WFD 2004 69 2 (2006) 334-342
43. Hirsch R., Ternes T.A., Haberer K., Mehlich A., Ballwanz F., and Kratz K.L. Determination of antibiotics in different water compartments via liquid chromatography-electrospray tandem mass spectrometry. J. Chromatogr. A 815 2 (1998) 213-223
44. Hirsch R., Ternes T.A., Haberer K., and Kratz K.L. Occurrence of antibiotics in the aquatic environment. Sci. Total Environ. 225 (1999) 109-118
45. JETACAR, 1999. The use of Antibiotics in food-producing animals: antibiotic-resistant bacteria in animals and humans. Joint Expert Advisory Committee on Antibiotic Resistance (JETACAR). A Division of the CDHAC & CDAFF, Canberra.
46. Johnston L., Mackay L., and Croft M. Determination of quinolones and fluoroquinolones in fish tissue and seafood by high-performance liquid chromatography with electrospray ionisation tandem mass spectrometric detection. J. Chromatogr. A 982 1 (2002) 97-109
47. Karthikeyan K.G., and Meyer M.T. Occurrence of antibiotics in wastewater treatment facilities in Wisconsin, USA. Sci. Total Environ. 361 1-3 (2006) 196-207
48. Khan S.J., and Ongerth J.E. Estimation of pharmaceutical residues in primary and secondary sewage sludge based on quantities of use and fugacity modelling. Water Sci. Technol. 46 3 (2002) 105-113
49. Khan S.J., and Ongerth J.E. Modelling of pharmaceutical residues in Australian sewage by quantities of use and fugacity calculations. Chemosphere 54 (2004) 355-367
50. Kinney C.A., Furlong E.T., Werner S.L., and Cahill J.D. Presence and distribution of wastewater-derived pharmaceuticals in soil irrigated with reclaimed water. Environ. Toxicol. Chem. 25 2 (2006) 317
51. Kinney, C.A., Furlong, E.T., Zaugg, S.D., Burkhardt, M.R., Werner, S.L., Cahill, J.D., Jorgensen, G.R., 2006b. Survey of organic wastewater contaminants in biosolids destined for land application. Environ. Sci. Technol.
52. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., and Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 36 6 (2002) 1202-1211
53. Kolpin D.W., Skopec M., Meyer M.T., Furlong E.T., and Zaugg S.D. Urban contribution of pharmaceuticals and other organic wastewater contaminants to streams during differing flow conditions. Sci. Total Environ. 328 1-3 (2004) 119-130
54. Kummerer K. Pharmaceuticals in the Environment (2004), Springer, Berlin
55. Kummerer K. Resistance in the environment. J. Antimicrob. Chemother. 54 2 (2004) 311-320
56. Lindsey, M.-E., Meyer, T.-M., Thurman, E.-M., 2001. Analysis of trace levels of sulfonamide and tetracycline antimicrobials in groundwater and surface water using solid-phase extraction and liquid chromatography/mass spectrometry. Anal. Chem.
57. Loffler D., and Ternes T.A. Determination of acidic pharmaceuticals, antibiotics and ivermectin in river sediment using liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1021 1-2 (2003) 133-144
58. Marsalek, J., Schaefer, K., Exall, K., Brannen, L., Aidun, B., 2002. Water reuse and recycling. In: CCME Linking Water Science to Policy Workshop Series. Canadian Council of Ministers of the Environment, Winnipeg, Manitoba, 39pp.
59. McArdell C.S., Molnar E., Suter M.J.F., and Giger W. Occurrence and fate of macrolide antibiotics in wastewater treatment plants and in the Glatt Valley watershed, Switzerland. Environ. Sci. Technol. 37 24 (2003) 5479-5486
60. Miao X.S., Bishay F., Chen M., and Metcalfe C.D. Occurrence of antimicrobials in the final effluents of wastewater treatment plants in Canada. Environ. Sci. Technol. 38 13 (2004) 3533-3541
61. OECD. The Price of Water: Trends in OECD Countries (1999), OECD Publishing
62. Oetken M., Nentwig G., Loffler D., Ternes T., and Oehlmann J. Effects of pharmaceuticals on aquatic invertebrates. Part I. The antiepileptic drug carbamazepine. Arch. Environ. Contam. Toxicol. 49 3 (2005) 353-361
63. Perez S., Eichhorn P., and Aga D.S. Evaluating the biodegradability of sulfamethazine, sulfamethoxazole, sulfathiazole, and trimethoprim at different stages of sewage treatment. Environ. Toxicol. Chem. 24 (2005) 1361-1367
64. Pomati F., Castiglioni S., Zuccato E., Fanelli R., Vigetti D., Rossetti C., and Calamari D. Effects of a complex mixture of therapeutic drugs at environmental levels on human embryonic cells. Environ. Sci. Technol. 40 7 (2006) 2442-2447
65. Qiang Z., Macauley J.J., Mormile M.R., Surampalli R., and Adams C.D. Treatment of antibiotics and antibiotic resistant bacteria in swine wastewater with free chlorine. J. Agric. Food Chem. 54 21 (2006) 8144-8154
66. Sengelov G., Halling-Sorensen B., and Aarestrup F.M. Susceptibility of Escherichia coli and Enterococcus faecium isolated from pigs and broiler chickens to tetracycline degradation products and distribution of tetracycline resistance determinants in E. coli from food animals. Vet. Microbiol. 95 1-2 (2003) 91-101
67. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 32 11 (1998) 3245-3260
68. TGA. Import Volumes of Antibiotics into Australia for Human, Veterinary and Feed Application 1992-2003 (2003), Therapuetic Goods Administration, Canberra
69. Toze S. Reuse of effluent water-benefits and risks. Agric. Water Manage. 80 1-3 (2006) 147-159
70. Van der Bruggen B., Schaep J., Wilms D., and Vandecasteele C. Influence of molecular size, polarity and charge on the retention of organic molecules by nanofiltration. J. Membr. Sci. 156 1 (1999) 29-41
71. Watkinson, A.J., Costanzo, S.D., 2005. A review of human & veterinary antibiotics in the aquatic environment: do they pose a risk in recycled wastewater? In: AWA Specialty Conference II in Public Health, 2005.Contaminants of Concern-Chemicals, Pathogens, Toxins, Canberra, ACT, AWA.
72. Westerhoff P., Yoon Y., Snyder S., and Wert E. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ. Sci. Technol. 39 17 (2005) 6649-6663
73. Wilson B.A., Smith V.H., deNoyelles F., and Larive C.K. Effects of three pharmaceutical and personal care products on natural freshwater algal assemblages. Environ. Sci. Technol. 37 9 (2003) 1713-1719
74. Xia K., Bhandari A., Das K., and Pillar G. Occurrence and fate of pharmaceuticals and personal care products (PPCPs) in biosolids. J. Environ. Qual. 34 1 (2005) 91-104
75. Yang S., and Carlson K. Evolution of antibiotic occurrence in a river through pristine, urban and agricultural landscapes. Water Res. 37 19 (2003) 4645-4656
76. Yang S., and Carlson K.H. Solid-phase extraction-high-performance liquid chromatography-ion trap mass spectrometry for analysis of trace concentrations of macrolide antibiotics in natural and waste water matrices. J. Chromatogr. A 1038 1-2 (2004) 141-155
77. Yang S., Cha J., and Carlson K. Simultaneous extraction and analysis of 11 tetracycline and sulfonamide antibiotics in influent and effluent domestic wastewater by solid-phase extraction and liquid chromatography-electrospray ionization tandem mass spectrometry. J. Chromatogr. A 1097 1-2 (2005) 40-53